Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Overexpression of IL-10 in Adipose Mesenchymal Stem Cells Promotes Wound Healing in Diabetic Mice.

Zhao H., Song F., Ouyang L., Shi X., Shang S.

Animal Study on Diabetic Foot, Chronic Wound, Scar, published in Stem Cells Int (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Stem Cells Int (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41613984
PMCID
PMC12848790
DOI
10.1155/sci/8861898

Abstract (original English)

Abstract Background: Diabetic ulcer is a serious chronic non-healing wound, which often leads to amputation or even death, causing great damage to the patients and their families. In recent years, stem cells are increasingly studied for tissue repair. Adipose tissue-derived mesenchymal stem cells (Adipose-derived mesenchymal stem cells, ADSCs) have the advantages of wide source and easy access. ADSCs can accelerate wound healing and reduce scar hyperplasia, especially for chronic wounds, patients cannot heal with traditional treatments, and ADSCs bring hope to these patients. Our study intends to overexpress IL-L 10 in ADSCs by genetic engineering technology, transplant ADSC-IL 10 to diabetic mouse wounds, and use the role of IL-10 in promoting M2 macrophages transformation, combined with ADSCs to achieve rapid healing of diabetic ulcer wounds. Methods : The expression of IL-10 protein in the supernatant of ADSC-IL10 was assessed using an ELISA kit. Flow cytometry was employed to analyze the surface stem cell markers (CD44, CD73, CD90, CD105) of ADSC-IL10. Additionally, the migration and proliferation of ADSC-IL10 were evaluated through cell scratch assays and MTT assays. The lipogenic marker PPARγ and the osteogenic marker RUNX2 were detected using fluorescent real-time quantitative PCR. Conditioned media from ADSC-IL10 (ADSC-IL10-CM) and ADSC-PCDH (ADSC-CM) were employed to c

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research